THC - Tenet Healthcare Corporation (THC) Q4 2023 Earnings Call Transcript
2024-02-08 16:01:03 ET
Tenet Healthcare Corporation (THC)
Q4 2023 Earnings Conference Call
February 08, 2024 10:00 AM ET
Company Participants
Will McDowell – Vice President-Investor Relations
Saum Sutaria – Chairman and Chief Executive Officer
Sun Park – Executive Vice President and Chief Financial Officer
Conference Call Participants
Cal Sternick – JPMorgan Chase & Company
A.J. Rice – UBS
Brian Tanquilut – Jefferies
Justin Lake – Wolfe Research
Kevin Fischbeck – Bank of America
Whit Mayo – Leerink Partners
Ben Hendrix – RBC Capital Markets
Josh Raskin – Nephron Research LLC
Sarah James – Cantor Fitzgerald
Pito Chickering – Deutsche Bank
Jason Cassorla – Citi
Stephen Baxter – Wells Fargo
Jamie Perse – Goldman Sachs
Presentation
Operator
Good afternoon. Welcome to Tenet Healthcare's Fourth Quarter 2023 Earnings Conference Call. After the speaker remarks, there will be a question-and-answer session for industry analysts. [Operator Instructions] Tenet respectfully asks that analysts limit themselves to one question each.
I'll now turn the call over to your host, Mr. Will McDowell, Vice President of Investor Relations. Mr. McDowell, you may begin.
Will McDowell
Good afternoon everyone and thank you for joining today's call. I am Will McDowell, Vice President of Investor Relations. We're pleased to have you join us for a discussion of Tenet's fourth quarter 2023 results as well as a discussion of our financial outlook.
Tenet's senior management participating in today's call will be Dr. Saum Sutaria, Chairman and Chief Executive Officer; and Sun Park, Executive Vice President and Chief Financial Officer.
Our webcast this morning includes a slide presentation, which has been posted to the Investor Relations section of our website, tenethealth.com. Listeners to this call are advised that certain statements made during our discussion today are forward-looking and represent management's expectations based on currently available information.
Actual results and plans could differ materially. Tenet is under no obligation to update any forward-looking statements based on subsequent information. Investors should take note of the cautionary statement slide included in today's presentation as well as the risk factors discussed in our most recent Form 10-K and other filings with the Securities and Exchange Commission....
Tenet Healthcare Corporation (THC) Q4 2023 Earnings Call Transcript